Latest News
Via The Motley Fool · April 25, 2025
HCA Healthcare delivered a strong first quarter, beating expectations in both earnings and revenue.
Via The Motley Fool · April 25, 2025
Via The Motley Fool · April 25, 2025
A credit card issuer might not seem like a recession-resistant business, but you might be surprised.
Via The Motley Fool · April 25, 2025
Comparing yourself to a broad average isn't always helpful, but it can give you some degree of perspective.
Via The Motley Fool · April 25, 2025
Pharmaceutical company AbbVie (NYSE:ABBV) beat Wall Street’s revenue expectations in Q1 CY2025, with sales up 8.4% year on year to $13.34 billion. Its non-GAAP profit of $2.46 per share was 2.6% above analysts’ consensus estimates.
Via StockStory · April 25, 2025
Investors are heavily discounting Alphabet's future. This may present an opportunity.
Via The Motley Fool · April 25, 2025
Will lower interest rates once again lead to higher crypto prices?
Via The Motley Fool · April 25, 2025
According to the Education Data Initiative report, the total outstanding debt in US student loans (federal and private) is a record $1.77 trillion for more than 42 million borrowers.
Via Talk Markets · April 25, 2025
COSTAR GROUP INC (NASDAQ:CSGP) Reveals Intriguing Technical Aspects. Indications Suggest NASDAQ:CSGP Could Be on the Verge of a Breakout. Here's What You Need to Know.
Via Chartmill · April 25, 2025
Via Benzinga · April 25, 2025
Trump's attacks on Harvard and deportation threats against foreign students is sparking global distrust in U.S. education.
Via Benzinga · April 25, 2025
The company also raised its outlook for 2025, though noted that guidance hike doesn't include potential pharma sector tariffs.
Via Investor's Business Daily · April 25, 2025
AUD/USD falls to near 0.6380 due to a recovery move in the US Dollar.
Via Talk Markets · April 25, 2025
Hospital operator HCA Healthcare (NYSE:HCA) reported Q1 CY2025 results beating Wall Street’s revenue expectations, with sales up 5.7% year on year to $18.32 billion. The company expects the full year’s revenue to be around $74.3 billion, close to analysts’ estimates. Its GAAP profit of $6.45 per share was 11.5% above analysts’ consensus estimates.
Via StockStory · April 25, 2025
Via The Motley Fool · April 25, 2025
Via The Motley Fool · April 25, 2025
The company is eyeing FDA approval for its drug, lenacapavir, for HIV prevention by mid-June.
Via Stocktwits · April 25, 2025
The stock is progressing through minute wave {i} within minor wave 5, indicating strength in the ongoing bullish momentum.
Via Talk Markets · April 25, 2025
TOLL BROTHERS INC is a hidden gem, featuring undervaluation and robust fundamentals. NYSE:TOL showcases decent financial health and profitability, coupled with an attractive price.
Via Chartmill · April 25, 2025
Freight transportation and logistics provider Saia (NASDAQ:SAIA) fell short of the market’s revenue expectations in Q1 CY2025 as sales rose 4.3% year on year to $787.6 million. Its GAAP profit of $1.86 per share was 32.6% below analysts’ consensus estimates.
Via StockStory · April 25, 2025